ABT vs. BDX: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABT and BDX, comparing key factors like performance, valuation metrics, dividends, and financial strength.
Company Overview
ABT’s market capitalization of 233.36 billion USD is substantially larger than BDX’s 49.98 billion USD, indicating a significant difference in their market valuations.
ABT’s beta of 0.74 points to significantly higher volatility compared to BDX (beta: 0.28), suggesting ABT has greater potential for both gains and losses relative to market movements.
| Symbol | ABT | BDX |
|---|---|---|
| Company Name | Abbott Laboratories | Becton, Dickinson and Company |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Medical - Instruments & Supplies |
| CEO | Mr. Robert B. Ford | Mr. Thomas E. Polen Jr. |
| Price | 134.13 USD | 174.39 USD |
| Market Cap | 233.36 billion USD | 49.98 billion USD |
| Beta | 0.74 | 0.28 |
| Exchange | NYSE | NYSE |
| IPO Date | March 17, 1980 | February 21, 1973 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ABT and BDX over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
This section compares the market valuation of ABT and BDX. Key takeaways regarding their valuation, when viewed within their industry context, are presented in the commentary that follows.
- BDX’s Forward PEG ratio of 5.92 is very high. This signifies that its current stock price is notably elevated compared to its anticipated earnings growth rate, possibly indicating that the market has already factored in, or even exceeded, realistic future performance expectations.
| Symbol | ABT | BDX |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 17.36 | 33.58 |
| Forward PEG Ratio (TTM) | 1.74 | 5.92 |
| Price-to-Sales Ratio (P/S, TTM) | 5.51 | 2.40 |
| Price-to-Book Ratio (P/B, TTM) | 4.80 | 1.99 |
| EV-to-EBITDA (TTM) | 21.44 | 19.51 |
| EV-to-Sales (TTM) | 5.67 | 3.29 |
Dividend Comparison
Both ABT and BDX offer dividend yields in a similar range (1.70% and 2.33%, respectively), indicating comparable approaches to shareholder distributions.
| Symbol | ABT | BDX |
|---|---|---|
| Dividend Yield (TTM) | 1.70% | 2.33% |
Financial Strength Metrics Comparison
Explore the financial strength details for ABT and BDX in the table below.
| Symbol | ABT | BDX |
|---|---|---|
| Current Ratio (TTM) | 1.78 | 1.13 |
| Quick Ratio (TTM) | 1.27 | 0.64 |
| Debt-to-Equity Ratio (TTM) | 0.27 | 0.76 |
| Debt-to-Asset Ratio (TTM) | 0.16 | 0.35 |
| Net Debt-to-EBITDA Ratio (TTM) | 0.60 | 5.29 |
| Interest Coverage Ratio (TTM) | 15.39 | 3.95 |